Literature DB >> 225412

Suppressive effects of interferon on syncytium formation by RD-114 virus in human transformed cells.

Y Tomita, T Kuwata.   

Abstract

The RD-114 virus rapidly induced syncytia in the human transformed cell lines, RSa, RSb and IFr. Treatment of the virus with heat or ultrasonic vibration completely eliminated the syncytium-forming activity. Irradiation with u.v.-light or treatment with beta-propiolactone (BPL) reduced but did not completely destroy the activity. Pre-treatment of the cells for 16 h with 25 to 500 units/ml of human leucocyte interferon (Le-IF) or fibroblast interferon (F-IF) significantly reduced formation of syncytia by active virus or inactivated (u.v. or BPL) virus. This activity of interferon was inhibited by treatment of the cells with cycloheximide. Interferon did not increase the binding of 3H-uridine-labelled RD-114 virus to the cells. It is postulated that interferon treatment altered the plasma membrane of the cells and thus reduced their capacity to fuse.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 225412     DOI: 10.1099/0022-1317-43-1-111

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

1.  Effect of cholera toxin on the antiviral and anticellular activities of human leukocyte interferon.

Authors:  A Fuse; T Kuwata
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

2.  Inhibition by interferon of Sendai virus cytolysis.

Authors:  T Sato; Y Tomita; T Kuwata
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

3.  Cell-cell fusion induced by measles virus amplifies the type I interferon response.

Authors:  F Herschke; S Plumet; T Duhen; O Azocar; J Druelle; D Laine; T F Wild; C Rabourdin-Combe; D Gerlier; H Valentin
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

4.  Rapid syncytium formation induced by Moloney murine sarcoma virus in 3T3/NIH cells and its delay by mouse interferon.

Authors:  M Aboud; M Huleihel
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.